← Leaderboards
Thomas J Montine
Vanderbilt University
$57,372,903
Attributed
$87,811,469
Total exposure
46
Grants
32
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $12.1M · FY2005–25$20M$15M$10M$5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$140,397,229 · 51
By mechanism
P50$38,447,503 · 14
R01$31,288,821 · 13
U01$18,671,835 · 3
U19$18,348,018 · 3
U41$9,607,992 · 1
P30$6,729,937 · 6
Top collaborators
- Sean Curtis Bendall12 shared
- Robert Michael Angelo10 shared
- David A Bennett9 shared
- Daniel H Geschwind9 shared
- Allan I Levey9 shared
- John Q. Trojanowski9 shared
- Juan Troncoso9 shared
- Michael J Maccoss8 shared
Most similar at Vanderbilt University
Same institution · by research overlap
- Galina I Lepesheva$5,937,767
- Timothy S Blackwell$28,109,454
- F Peter Guengerich$48,178,939
- Kelly A Birdwell$3,186,569
- Nancy J Olsen$6,548,556
Others in their field
Top investigators on “Alzheimer&Apos”
- Jose A Luchsinger · Columbia University Health Sciences$56,595,040
- Eric M Reiman · Banner Health$48,982,487
- Yadong Huang · J. David Gladstone Institutes$40,311,515
- Lindsay A. Farrer · Boston University Medical Campus$34,189,802
- David M Holtzman · Washington University$28,985,806
- Michael W Weiner · Northern California Institute Res &Educ$28,197,224
Research focus
Alzheimer&AposS DiseaseResourcesDementiaBrainCommunitiesImpaired CognitionPathologicNeuropathologyInnovationUniversitiesGeneticBaseUnited States National Institutes Of HealthMolecularScientistLinkProteinsAutopsyPathway InteractionsResearch PersonnelProgramsCognitiveNeurodegenerative Disorders
Grant awards (199)
Multi-omic functional assessment of novel AD variants using high-throughput and single-cell technologies$1,622,284
U01 · FY2025 · AG · contact PI
Uncovering mechanisms of protection from Alzheimer's disease in CHIP using human cohorts and biosamples$1,400,625
R01 · FY2025 · AG
Neuropath Core$372,067
P30 · FY2025 · AG · contact PI
Next Generation Translational Proteomics for Alzheimer's and Related Dementias$3,132,122
U19 · FY2024 · AG
Multi-omic functional assessment of novel AD variants using high-throughput and single-cell technologies$1,655,392
U01 · FY2024 · AG · contact PI
Uncovering mechanisms of protection from Alzheimer's disease in CHIP using human cohorts and biosamples$1,456,409
R01 · FY2024 · AG
Project 2: Particle and brain mapping of CSF proteins using elemental reporters with mass spectrometry$488,875
U19 · FY2024 · AG · contact PI
Core D - Neuropathology Core$408,114
P30 · FY2024 · AG · contact PI
Neuropath Core$372,577
P30 · FY2024 · AG · contact PI
Next Generation Translational Proteomics for Alzheimer's and Related Dementias$3,144,562
U19 · FY2023 · AG
Neuropathology of synapses in AD and ADRD$2,155,924
RF1 · FY2023 · AG · contact PI
Multi-omic functional assessment of novel AD variants using high-throughput and single-cell technologies$1,660,007
U01 · FY2023 · AG · contact PI
Identifying the Genetic Etiology of Neuropathology for Alzheimer Disease and Related Dementias$741,270
R01 · FY2023 · AG
Project 2: Particle and brain mapping of CSF proteins using elemental reporters with mass spectrometry$488,875
U19 · FY2023 · AG · contact PI
Neuropath Core$379,727
P30 · FY2023 · AG · contact PI
Neuropathology Core$270,540
P30 · FY2023 · AG · contact PI
Next Generation Translational Proteomics for Alzheimer's and Related Dementias$3,144,562
U19 · FY2022 · AG
Multi-omic functional assessment of novel AD variants using high-throughput and single-cell technologies$1,669,192
U01 · FY2022 · AG · contact PI
Identifying the Genetic Etiology of Neuropathology for Alzheimer Disease and Related Dementias$741,270
R01 · FY2022 · AG
Project 2: Particle and brain mapping of CSF proteins using elemental reporters with mass spectrometry$461,825
U19 · FY2022 · AG · contact PI
Recombineering-based no-cleavage gene-editing toolkit for large-scale genome engineering and functional screening$417,908
R01 · FY2022 · GM · contact PI
Neuropath Core$381,928
P30 · FY2022 · AG · contact PI
Neuropathology Core$365,632
P30 · FY2022 · AG · contact PI
Neuropathology Core$287,538
P30 · FY2022 · AG · contact PI
Next Generation Translational Proteomics for Alzheimer's and Related Dementias$3,144,564
U19 · FY2021 · AG
Multi-omic functional assessment of novel AD variants using high-throughput and single-cell technologies$1,698,183
U01 · FY2021 · AG · contact PI
MIRIAD - Multiplexed Imaging of Resilience In Alzheimers Disease$865,036
R01 · FY2021 · AG
Identifying the Genetic Etiology of Neuropathology for Alzheimer Disease and Related Dementias$741,270
R01 · FY2021 · AG
The Phenotypic Landscape of Cognitive Decline as Revealed by Next-Generation Multiplexed Ion Beam Imaging$502,002
R01 · FY2021 · AG
Project 2: Particle and brain mapping of CSF proteins using elemental reporters with mass spectrometry$488,875
U19 · FY2021 · AG · contact PI
Neuropathology Core$408,932
P30 · FY2021 · AG · contact PI
Neuropath Core$374,841
P30 · FY2021 · AG · contact PI
Neuropathology Core$360,550
P30 · FY2021 · AG · contact PI
Next Generation Translational Proteomics for Alzheimer's and Related Dementias$3,351,008
U19 · FY2020 · AG
Clinical Genome Resource (ClinGen)$2,943,376
U41 · FY2020 · HG · contact PI
MIRIAD - Multiplexed Imaging of Resilience In Alzheimers Disease$879,166
R01 · FY2020 · AG
Identifying the Genetic Etiology of Neuropathology for Alzheimer Disease and Related Dementias$771,970
R01 · FY2020 · AG
The Phenotypic Landscape of Cognitive Decline as Revealed by Next-Generation Multiplexed Ion Beam Imaging$514,173
R01 · FY2020 · AG
Project 2: Particle and brain mapping of CSF proteins using elemental reporters with mass spectrometry$502,750
U19 · FY2020 · AG · contact PI
Neuropathology Core$353,568
P30 · FY2020 · AG · contact PI
Core D: Neuropathology Core$346,250
P30 · FY2020 · AG · contact PI
Neuropathology Core$310,757
P30 · FY2020 · AG · contact PI
Pacific Udall Center$50,000
P50 · FY2020 · NS · contact PI
Clinical Genome Resource (ClinGen)$2,990,699
U41 · FY2019 · HG · contact PI
Pacific Udall Center$1,495,767
P50 · FY2019 · NS · contact PI
MIRIAD - Multiplexed Imaging of Resilience In Alzheimers Disease$893,296
R01 · FY2019 · AG
Leveraging Glycomics to Characterize a Molecular Signature of Alzheimer's Disease$785,872
R56 · FY2019 · AG
Identifying the Genetic Etiology of Neuropathology for Alzheimer Disease and Related Dementias$785,345
R01 · FY2019 · AG
Clinical Genome Resource (ClinGen)$681,711
U41 · FY2019 · HG · contact PI
The Phenotypic Landscape of Cognitive Decline as Revealed by Next-Generation Multiplexed Ion Beam Imaging$525,940
R01 · FY2019 · AG
Core D: Neuropathology Core$335,575
P30 · FY2019 · AG · contact PI
Core D: Neuropathology Core$181,441
P50 · FY2019 · AG · contact PI
Pacific Udall Center$102,177
P50 · FY2019 · NS · contact PI
Pacific Udall Center$1,500
P50 · FY2019 · NS · contact PI
Clinical Genome Resource (ClinGen)$2,992,206
U41 · FY2018 · HG · contact PI
Discovery of Novel Proteomic Targets for Treatment of Alzheimer's Disease$1,619,042
U01 · FY2018 · AG
Pacific Udall Center$1,523,128
P50 · FY2018 · NS · contact PI
MIRIAD - Multiplexed Imaging of Resilience In Alzheimers Disease$905,050
R01 · FY2018 · AG
Administrative Core$861,516
P50 · FY2018 · AG · contact PI
Native Alzheimer's Disease Resource Center for Minority Aging Research (NAD-RCMAR)$580,586
P30 · FY2018 · AG
The Phenotypic Landscape of Cognitive Decline as Revealed by Next-Generation Multiplexed Ion Beam Imaging$537,162
R01 · FY2018 · AG
Core D: Neuropathology Core$244,719
P30 · FY2018 · AG · contact PI
Pacific Udall Center$1,500
P50 · FY2018 · NS · contact PI
Neuropathologic substrates for motor and cognitive impairment in three existing cohort studies of Alzheimer's disease and related dementias$3,880,240
UF1 · FY2017 · AG · contact PI
Discovery of Novel Proteomic Targets for Treatment of Alzheimer's Disease$1,631,705
U01 · FY2017 · AG
Pacific Udall Center$1,550,974
P50 · FY2017 · NS · contact PI
MIRIAD - Multiplexed Imaging of Resilience In Alzheimers Disease$934,771
R01 · FY2017 · AG
Administrative Core$843,845
P50 · FY2017 · AG · contact PI
The Phenotypic Landscape of Cognitive Decline as Revealed by Next-Generation Multiplexed Ion Beam Imaging$562,550
R01 · FY2017 · AG
Core D: Neuropathology Core$274,288
P30 · FY2017 · AG · contact PI
Molecular Phenotyping in Alzheimer's Disease$157,000
RF1 · FY2017 · AG · contact PI
Discovery of Novel Proteomic Targets in Alzheimer's Disease$156,000
U01 · FY2017 · AG
Molecular Phenotyping in Alzheimer's Disease$3,932,542
RF1 · FY2016 · AG · contact PI
Cognitive resilience to Alzheimer neuropathologic changes in the Honolulu-Asia Aging Study and the Nun Study$2,640,684
UF1 · FY2016 · AG
Pacific Northwest Udall Center$1,699,692
P50 · FY2016 · NS · contact PI
Discovery of Novel Proteomic Targets for Treatment of Alzheimer's Disease$1,541,709
U01 · FY2016 · AG
Administrative Core$831,845
P50 · FY2016 · AG · contact PI
White matter damage in age-related cognitive decline$649,151
R01 · FY2016 · AG · contact PI
Core D: Neuropathology Core$301,748
P30 · FY2016 · AG · contact PI
Core D: Neuropathology Core$164,780
P50 · FY2016 · AG · contact PI
Discovery of Novel Proteomic Targets for Treatment of Alzheimer's Disease$160,872
U01 · FY2016 · AG
White Matter Damage in Age-Related Cognitive Decline$154,096
R01 · FY2016 · AG · contact PI
Pacific Northwest Udall Center$1,952,761
P50 · FY2015 · NS · contact PI
Discovery of Novel Proteomic Targets for Treatment of Alzheimer's Disease$1,516,903
U01 · FY2015 · AG
Administrative Core$847,321
P50 · FY2015 · AG · contact PI
White matter damage in age-related cognitive decline$667,203
R01 · FY2015 · AG · contact PI
Neuropathologic research on dementia using Nun Study and HAAS data$576,122
U01 · FY2015 · AG · contact PI
Targeting the kynurenine pathway in Alzheimer's disease$462,892
R01 · FY2015 · AG
Genetic risk for PD-related cognitive impairment and it disease mechanisms$253,395
P50 · FY2015 · NS · contact PI
Administrative Core$153,130
P50 · FY2015 · NS · contact PI
Discovery of Novel Proteomic Targets for Treatment of Alzheimer's Disease$132,600
U01 · FY2015 · AG
Neuropathologic research on dementia using Nun Study and HAAS data$86,823
U01 · FY2015 · AG · contact PI
Alzheimer's Disease Research Center$2,762,689
P50 · FY2014 · AG · contact PI
Discovery of Novel Proteomic Targets for Treatment of Alzheimer's Disease$1,530,583
U01 · FY2014 · AG
Pacific Northwest Udall Center$1,291,455
P50 · FY2014 · NS · contact PI
White matter damage in age-related cognitive decline$687,839
R01 · FY2014 · AG · contact PI
Neuropathologic research on dementia using Nun Study and HAAS data$596,190
U01 · FY2014 · AG · contact PI
NEUROPATHOLOGY AND TARGETED MOLECULAR TESTING CORE$522,275
P50 · FY2014 · AG · contact PI
Targeting the kynurenine pathway in Alzheimer's disease$506,738
R01 · FY2014 · AG
CSF PROTEOME OF GERIATRIC DEMENTIA: CSF PROTEIN PROFILING OF CNS INSULIN ACTIVITY$187,533
P50 · FY2014 · AG · contact PI
ADMINISTRATIVE AND OUTREACH$122,763
P50 · FY2014 · NS · contact PI
Discovery of Novel Proteomic Targets for Treatment of Alzheimer's Disease$110,684
U01 · FY2014 · AG
Neuropathologic research on dementia using Nun Study and HAAS data$79,820
U01 · FY2014 · AG · contact PI
White matter damage in age-related cognitive decline$49,810
R01 · FY2014 · AG · contact PI
Udall Center Director's meeting poster award$2,500
P50 · FY2014 · NS · contact PI
Alzheimer's Disease Research Center$2,591,473
P50 · FY2013 · AG · contact PI
Pacific Northwest Udall Center$1,641,961
P50 · FY2013 · NS · contact PI
White matter damage in age-related cognitive decline$650,008
R01 · FY2013 · AG · contact PI
Neuropathologic research on dementia using Nun Study and HAAS data$627,724
U01 · FY2013 · AG · contact PI
NEUROPATHOLOGY AND TARGETED MOLECULAR TESTING CORE$489,915
P50 · FY2013 · AG · contact PI
Environmental Pathology/Toxicology Training Program$441,818
T32 · FY2013 · ES · contact PI
Toxicants and innate immunity in models of Parkinson's disease$337,136
R01 · FY2013 · ES · contact PI
Selective and Restricted Denervation In Parkinson's Disease With Cognitive Impair$178,840
P50 · FY2013 · NS · contact PI
CSF PROTEOME OF GERIATRIC DEMENTIA: CSF PROTEIN PROFILING OF CNS INSULIN ACTIVITY$176,829
P50 · FY2013 · AG · contact PI
Administrative and Outreach$146,967
P50 · FY2013 · NS · contact PI
Neurobehavior, Neuroendocrinology, and Genetics of AD$71,531
T32 · FY2013 · AG · contact PI
Pacific Northwest Udall Center$5,000
P50 · FY2013 · NS · contact PI
Alzheimer's Disease Research Center$2,778,928
P50 · FY2012 · AG · contact PI
Pacific Northwest Udall Center$1,707,281
P50 · FY2012 · NS · contact PI
White matter damage in age-related cognitive decline$701,464
R01 · FY2012 · AG · contact PI
NEUROPATHOLOGY AND TARGETED MOLECULAR TESTING CORE$525,364
P50 · FY2012 · AG · contact PI
Environmental Pathology/Toxicology Training Program$444,274
T32 · FY2012 · ES · contact PI
Neurobehavior, Neuroendocrinology, and Genetics of AD$387,765
T32 · FY2012 · AG · contact PI
Toxicants and innate immunity in models of Parkinson's disease$344,016
R01 · FY2012 · ES · contact PI
Selective and Restricted Denervation In Parkinson's Disease With Cognitive Impair$222,577
P50 · FY2012 · NS · contact PI
CSF PROTEOME OF GERIATRIC DEMENTIA: CSF PROTEIN PROFILING OF CNS INSULIN ACTIVITY$190,628
P50 · FY2012 · AG · contact PI
Administrative and Outreach$182,357
P50 · FY2012 · NS · contact PI
Pacific Northwest Udall Center$1,684,578
P50 · FY2011 · NS · contact PI
NEUROPATHOLOGY AND TARGETED MOLECULAR TESTING CORE$539,792
P50 · FY2011 · AG · contact PI
Environmental Pathology/Toxicology Training Program$486,001
T32 · FY2011 · ES · contact PI
Toxicants and innate immunity in models of Parkinson's disease$344,016
R01 · FY2011 · ES · contact PI
CSF PROTEOME OF GERIATRIC DEMENTIA: CSF PROTEIN PROFILING OF CNS INSULIN ACTIVITY$196,908
P50 · FY2011 · AG · contact PI
Selective and Restricted Denervation In Parkinson's Disease With Cognitive Impair$182,483
P50 · FY2011 · NS · contact PI
Administrative and Outreach$149,990
P50 · FY2011 · NS · contact PI
Pacific Northwest Udall Center$1,656,290
P50 · FY2010 · NS · contact PI
White matter damage in age-related cognitive decline$1,249,219
R01 · FY2010 · AG · contact PI
NEUROPATHOLOGY AND TARGETED MOLECULAR TESTING CORE$533,119
P50 · FY2010 · AG · contact PI
Environmental Pathology/Toxicology Training Program$449,368
T32 · FY2010 · ES · contact PI
Toxicants and innate immunity in models of Parkinson's disease$347,490
R01 · FY2010 · ES · contact PI
Selective and Restricted Denervation In Parkinson's Disease With Cognitive Impair$213,413
P50 · FY2010 · NS · contact PI
CSF PROTEOME OF GERIATRIC DEMENTIA: CSF PROTEIN PROFILING OF CNS INSULIN ACTIVITY$195,000
P50 · FY2010 · AG · contact PI
Administrative and Outreach$175,993
P50 · FY2010 · NS · contact PI
Pacific Northwest Udall Center$172,000
P50 · FY2010 · NS · contact PI
Pacific Northwest Udall Center$158,543
P50 · FY2010 · NS · contact PI
Pacific Northwest Udall Center$1,650,167
P50 · FY2009 · NS · contact PI
White matter damage in age-related cognitive decline$1,277,702
R01 · FY2009 · AG · contact PI
Environmental Pathology/Toxicology Training Program$463,270
T32 · FY2009 · ES · contact PI
Toxicants and innate immunity in models of Parkinson's disease$351,000
R01 · FY2009 · ES · contact PI
CORE--NEUROPATHOLOGY$325,340
P50 · FY2009 · AG · contact PI
Pharmaconeuropathology of Brain Aging and Dementia$278,886
R01 · FY2009 · AG · contact PI
CSF PROTEOME OF GERIATRIC DEMENTIA$192,277
P50 · FY2009 · AG · contact PI
Selective and Restricted Denervation In Parkinson's Disease With Cognitive Impair$168,163
P50 · FY2009 · NS · contact PI
Administrative and Outreach$139,808
P50 · FY2009 · NS · contact PI
Pharmaconeuropathology of Brain Aging and Dementia$91,662
R01 · FY2009 · AG · contact PI
Environmental Pathology/Toxicology Training Program$409,131
T32 · FY2008 · ES · contact PI
CORE--NEUROPATHOLOGY$318,208
P50 · FY2008 · AG · contact PI
Pharmaconeuropathology of Brain Aging and Dementia$279,267
R01 · FY2008 · AG · contact PI
Proteomic Discovery in Parkinson-Dementia Complex of Guam$188,042
R21 · FY2008 · AG · contact PI
CSF PROTEOME OF GERIATRIC DEMENTIA$188,039
P50 · FY2008 · AG · contact PI
Characterization of Dementia with Lewy Bodies: A Collaborative Study$531,192
R01 · FY2007 · NS · contact PI
CORE--NEUROPATHOLOGY$317,393
P50 · FY2007 · AG · contact PI
Lipid Oxidation Products in Alzheimer's Disease$306,645
R01 · FY2007 · AG · contact PI
Pharmaconeuropathology of Brain Aging and Dementia$285,340
R01 · FY2007 · AG · contact PI
CSF PROTEOME OF GERIATRIC DEMENTIA$187,711
P50 · FY2007 · AG · contact PI
Proteomic Discovery in Parkinson-Dementia Complex of Guam$159,900
R21 · FY2007 · AG · contact PI
Dementia with Lewy Bodies: A Collaborative Study$541,830
R01 · FY2006 · NS · contact PI
Lipid Oxidation Products in Alzheimer's Disease$427,649
R01 · FY2006 · AG · contact PI
Pharmaconeuropathology of Brain Aging and Dementia$294,231
R01 · FY2006 · AG · contact PI
CORE--NEUROPATHOLOGY$217,281
P50 · FY2006 · AG · contact PI
CSF PROTEOME OF GERIATRIC DEMENTIA$128,607
P50 · FY2006 · AG · contact PI
Dementia with Lewy Bodies: A Collaborative Study$549,140
R01 · FY2005 · NS
Lipid Oxidation Products in Alzheimer's Disease$435,550
R01 · FY2005 · AG
Pharmaconeuropathology of Brain Aging and Dementia$294,071
R01 · FY2005 · AG
CORE--NEUROPATHOLOGY$211,159
P50 · FY2005 · AG
CSF PROTEOME OF GERIATRIC DEMENTIA$125,000
P50 · FY2005 · AG
Dementia with Lewy Bodies: A Collaborative Study$540,742
R01 · FY2004 · NS
Lipid Oxidation Products in Alzheimer's Disease$324,904
R01 · FY2004 · AG
CATECHOL THIOETHERS IN PARKINSON'S DISEASE$277,524
R01 · FY2004 · ES
Lipid Oxidation Products in Alzheimer's Disease$108,326
R01 · FY2004 · AG
Dementia with Lewy Bodies: A Collaborative Study$529,034
R01 · FY2003 · NS
Lipid Oxidation Products in Alzheimer's Disease$338,276
R01 · FY2003 · AG
LIPID PEROXIDATION AND APOE IN ALZHEIMERS DISEASE$275,227
R01 · FY2003 · AG
CATECHOL THIOETHERS IN PARKINSON'S DISEASE$270,018
R01 · FY2003 · ES
LIPID PEROXIDATION AND APOE IN ALZHEIMERS DISEASE$266,555
R01 · FY2002 · AG
CATECHOL THIOETHERS IN PARKINSON'S DISEASE$220,874
R01 · FY2002 · ES
Dendritic spines in Parkinson's disease$162,335
P01 · FY2002 · NS
CATECHOL THIOETHERS IN PARKINSON'S DISEASE$41,768
R01 · FY2002 · ES
LIPID PEROXIDATION AND APOE IN ALZHEIMERS DISEASE$1,132
R01 · FY2002 · AG
QUANTIFICATION OF BRAIN OXIDATIVE DAMAGE IN ALZHEIMER'S DISEASE PATIENTS$0
M01 · FY2002 · RR
LIPID PEROXIDATION AND APOE IN ALZHEIMERS DISEASE$246,668
R01 · FY2001 · AG
CATECHOL THIOETHERS IN PARKINSON'S DISEASE$225,177
R01 · FY2001 · ES
QUANTIFICATION OF BRAIN OXIDATIVE DAMAGE IN ALZHEIMER'S DISEASE PATIENTS$0
M01 · FY2001 · RR
QUANTIFICATION OF BRAIN OXIDATIVE DAMAGE IN ALZHEIMER'S DISEASE PATIENTS$0
M01 · FY2001 · RR
QUANTIFICATION OF BRAIN OXIDATIVE DAMAGE IN ALZHEIMER'S DISEASE PATIENTS$0
M01 · FY2001 · RR
Lipid peroxidation, antioxidants in AD$178,134
P50 · FY2000 · AG
CATECHOL THIOETHERS IN PARKINSON'S DISEASE$176,618
R01 · FY2000 · ES
LIPID PEROXIDATION AND APOE IN ALZHEIMERS DISEASE$175,522
R01 · FY2000 · AG
CROSSLINKING OF APOE AND TAU IN ALZHEIMERS DISEASE$87,426
K08 · FY2000 · AG
QUANTIFICATION OF BRAIN OXIDATIVE DAMAGE IN ALZHEIMER'S DISEASE PATIENTS$0
M01 · FY2000 · RR